CONGENICA LTD

08273616
Active Cambridge

Research and experimental development on biotechnology

43 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CONGENICA LTD

08273616

Research and experimental development on biotechnology

Founded 30 Oct 2012 Active Cambridge, England 43 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 3 months remaining
Confirmation Submitted 16 Dec 2025 Next due 13 Nov 2026 4 months remaining
Net assets £-3M £3M 2024 year on year
Total assets £3M £3M 2024 year on year
Total Liabilities £6M £281K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Bic Wellcome Genome Campus Hinxton Cambridge CB10 1DR England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CONGENICA LTD (08273616), an active life sciences and medical technology company based in Cambridge, England. Incorporated 30 Oct 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2017–2024)

Cash in Bank

£1.21M

Decreased by £2.55M (-68%)

Net Assets

-£2.64M

Decreased by £2.74M (-2780%)

Total Liabilities

£5.77M

Decreased by £281.12k (-5%)

Turnover

£4.67M

Decreased by £196.05k (-4%)

Employees

43

Decreased by 46 (-52%)

Debt Ratio

184%

Increased by 86 (+88%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5
Grants 3

Investors (15)

Investor NameInvestor SinceParticipating Rounds
Investor 6Dec 2014Series A, Series C, Series B, Seed
Investor 7Apr 2015Series A, Series B
Investor 4Apr 2017Series C, Series B

Share Capital

Share Capital

Share allotments and capital structure

26 Allotments 47,765,845 Shares £31978.71m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Dec 202447,113£471.13£0.01
16 Aug 20231,600£16£0.01
29 Jun 202390,000£900£0.01
5 Jan 202321,313£4.54m£213.13
1 Dec 202266,667£44.44m£666.67

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (50)

Seqone Sas
42.1%
25,087,820
Seqone Sas
27.4%
16,338,318

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Parkwalk Advisors Ltd

Ceased 22 Oct 2020

Ceased
Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Dec 2025Confirmation StatementConfirmation statement made on 30 Oct 2025 with updates
16 Dec 2025OfficersAppointment of Dr Alexander Kurze as director on 28 Nov 2025
16 Dec 2025OfficersAppointment of Pramex International Ltd as director on 16 Dec 2025
3 Sept 2025ResolutionResolutions
2 Sept 2025IncorporationMemorandum Articles
16 Dec 2025 Confirmation Statement

Confirmation statement made on 30 Oct 2025 with updates

16 Dec 2025 Officers

Appointment of Dr Alexander Kurze as director on 28 Nov 2025

16 Dec 2025 Officers

Appointment of Pramex International Ltd as director on 16 Dec 2025

3 Sept 2025 Resolution

Resolutions

2 Sept 2025 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Confirmation statement made on 30 Oct 2025 with updates

6 months ago on 16 Dec 2025

Appointment of Dr Alexander Kurze as director on 28 Nov 2025

6 months ago on 16 Dec 2025

Appointment of Pramex International Ltd as director on 16 Dec 2025

6 months ago on 16 Dec 2025

Resolutions

9 months ago on 3 Sept 2025

Memorandum Articles

9 months ago on 2 Sept 2025